5-EPI-DEOXYRHAMNOJIRIMYCIN IS A POTENT INHIBITOR OF AN ALPHA-L-RHAMNOSIDASE - 5-EPI-DEOXYMANNOJIRIMYCIN IS NOT A POTENT INHIBITOR OF AN ALPHA-D-MANNOSIDASE
Bg. Davis et al., 5-EPI-DEOXYRHAMNOJIRIMYCIN IS A POTENT INHIBITOR OF AN ALPHA-L-RHAMNOSIDASE - 5-EPI-DEOXYMANNOJIRIMYCIN IS NOT A POTENT INHIBITOR OF AN ALPHA-D-MANNOSIDASE, Tetrahedron : asymmetry, 9(16), 1998, pp. 2947-2960
Whereas deoxyrhamnojirimycin (LRJ) 1 shows no significant inhibition o
f naringinase (an alpha-L-rhamnosidase), its C-5 epimer 2 is a potent
and specific inhibitor of the enzyme and demonstrates the value of una
mbiguous chemical synthesis of such materials in the evaluation of the
ir biological properties. In contrast, moderately weak inhibition towa
rds an alpha-D-mannosidase is shown by both deoxymannojirimycin (DMJ)
5 and its C-5 epimer 6. Mimics of L-rhamnose which are recognised by e
nzymes that synthesise or process L-rhamnose may inhibit el ther the b
iosynthesis of the sugar or its incorporation into mycobacterial cell
walls, providing new strategies for the treatment of diseases such as
tuberculosis and leprosy. Molecular modelling studies provide a ration
ale for the surprisingly potent activity of the C-S epimer 2 compared
with LRJ 1 and support a general hypothesis that potent piperidine gly
cosidase inhibitors mimic the H-4(3) conformation Of the relevant glyc
opyranosyl cation intermediate. (C) 1998 Elsevier Science Ltd. All rig
hts reserved.